Manglende evidens i forebyggelse af kemoterapiinduceret kvalme og opkastning hos børn og unge

Translated title of the contribution: Insufficient evidence in prophylactic therapy of chemotherapy-induced nausea and vomiting in children and adolescents

Astrid Eliasen, Michael Callesen, Kim Peder Dalhoff, Catherine Rechnitzer, Kjeld Schmiegelow, Henrik Schrøder, Ruta Tuckuviene, Helle Holst

Research output: Contribution to journalJournal articleResearchpeer-review

Abstract

Nausea and vomiting are burdensome side effects of chemotherapy. Vomiting is observed in up to 60% of treated children. An appropriate and effective antiemetic regimen has the potential to eradicate or reduce the symptoms. Differences in local guidelines characterise the antiemetic treatment across the four Danish paediatric oncology departments because the overall knowledge of the most effective antiemetics is incomplete. There is an unmet need for research, which can promote evidence-based guidelines. The impact of host genome polymorphisms should be included in the research.
Translated title of the contributionInsufficient evidence in prophylactic therapy of chemotherapy-induced nausea and vomiting in children and adolescents
Original languageDanish
Article numberV11170851
JournalUgeskrift for Laeger
Volume181
Issue number9
ISSN0041-5782
Publication statusPublished - 2019

Fingerprint Dive into the research topics of 'Insufficient evidence in prophylactic therapy of chemotherapy-induced nausea and vomiting in children and adolescents'. Together they form a unique fingerprint.

  • Cite this